Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion
J Gurevitch,
I Frolkis,
Y Yuhas,
B Lifschitz-Mercer,
E Berger,
Y Paz,
M Matsa,
A Kramer,
and
R Mohr
Department of Thoracic and Cardiovascular Surgery Ischilov Hospital and Institute of Pathology, Elias Sourasky-Tel-Aviv Medical Center, Israel.
OBJECTIVES: This study sought to assess the importance of locally released or paracrine myocardial tumor necrosis factor-alpha (TNF-alpha) in the evolution of postischemic myocardial dysfunction and to use immunohistochemical studies to localize TNF-alpha within the myocardium. BACKGROUND: TNF-alpha is implicated as a systemic mediator in the development of myocardial ischemia-reperfusion injury by promoting leukocyte myocardial infiltration, and it has been shown to originate from noncardiac peripheral mononuclear cells. We have recently documented in a blood-free environment the release of TNF-alpha from the ischemic-reperfused myocardium. METHODS: Isolated rat hearts undergoing 1 h of global cardioplegia-induced ischemia and 30 min of reperfusion were investigated with use of the modified Langendorff model. Hearts were randomly divided into three subgroups: group A, control group; and groups B and C, isolated hearts receiving cardioplegic solution containing monoclonal hamster antimurine TNF-alpha antibodies (group B) or hamster IgG (group C). RESULTS: Significant amounts of TNF-alpha were detected in group A and group C effluent on 1 min of reperfusion (752 +/- 212 and 958 +/- 409 pmol/ml, respectively). However, in group B, TNF-alpha was below detectable levels. In this group, postischemic left ventricular peak systolic pressures, first derivative of the rise in left ventricular pressure (dP/dtmax), pressure-time integral, coronary flow and O2 consumption improved (analysis of variance [ANOVA] p < 0.0001 for all variables) compared with values in groups A and C; creatine kinase levels decreased (p < 0.005); and myocardial structure was preserved. Immunohistochemical staining localized TNF-alpha to cardiac myocytes and to endothelial cells. CONCLUSIONS: Anti-TNF-alpha neutralizes local TNF-alpha release from cardiac myocytes after ischemia and improves myocardial recovery during reperfusion, indicating that postischemic paracrine TNF-alpha release plays an active role in myocardial dysfunction.
This article has been cited by other articles:

|
 |

|
 |
 
S. Wu, R. Yin, R. Ernest, Y. Li, O. Zhelyabovska, J. Luo, Y. Yang, and Q. Yang
Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF-{kappa}B signalling
Cardiovasc Res,
October 1, 2009;
84(1):
119 - 126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Fokkema, P. J. Vlaar, M. Vogelzang, Y. L. Gu, M. A. Kampinga, B. J. de Smet, G. A. Jessurun, R. L. Anthonio, A. F. van den Heuvel, E.-S. Tan, et al.
Effect of High-Dose Intracoronary Adenosine Administration During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: A Randomized Controlled Trial
Circ Cardiovasc Interv,
August 1, 2009;
2(4):
323 - 329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Qiu, L. Zheng, H. Gu, D. Chen, and Y. Chen
Comparison between adult and infant lung injury in a rabbit ischemia-reperfusion model.
J. Thorac. Cardiovasc. Surg.,
August 1, 2008;
136(2):
352 - 359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Galinanes, M. James, V. Codd, A. Baxi, and L. Hadjinikolaou
TNF-{alpha} gene promoter polymorphism at nucleotide -308 and the inflammatory response and oxidative stress induced by cardiac surgery: role of heart failure and medical treatment
Eur J Cardiothorac Surg,
August 1, 2008;
34(2):
332 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Cha, Z. Wang, L. Ao, N. Zou, C. A. Dinarello, A. Banerjee, D. A. Fullerton, and X. Meng
Cytokines Link Toll-Like Receptor 4 Signaling to Cardiac Dysfunction After Global Myocardial Ischemia
Ann. Thorac. Surg.,
May 1, 2008;
85(5):
1678 - 1685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Gazoni, C. G. Tribble, M. Q. Zhao, E. B. Unger, R. A. Farrar, P. I. Ellman, L. G. Fernandez, V. E. Laubach, and I. L. Kron
Pulmonary Macrophage Inhibition and Inhaled Nitric Oxide Attenuate Lung Ischemia-Reperfusion Injury
Ann. Thorac. Surg.,
July 1, 2007;
84(1):
247 - 253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. J. Liakopoulos, N. Teucher, C. Muhlfeld, P. Middel, G. Heusch, F. A. Schoendube, and H. Dorge
Prevention of TNF{alpha}-associated myocardial dysfunction resulting from cardiopulmonary bypass and cardioplegic arrest by glucocorticoid treatment
Eur J Cardiothorac Surg,
August 1, 2006;
30(2):
263 - 270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wang, B. M. Tsai, P. R. Crisostomo, and D. R. Meldrum
Tumor Necrosis Factor Receptor 1 Signaling Resistance in the Female Myocardium During Ischemia
Circulation,
July 4, 2006;
114(1_suppl):
I-282 - I-289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Xu, I. A. Arenas, S. J. Armstrong, W. C. Plahta, H. Xu, and S. T. Davidge
Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-{alpha}
Cardiovasc Res,
March 1, 2006;
69(4):
836 - 844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Bonvini, T. Hendiri, and E. Camenzind
Inflammatory response post-myocardial infarction and reperfusion: a new therapeutic target?
Eur. Heart J. Suppl.,
October 1, 2005;
7(suppl_I):
I27 - I36.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Pevni, I. Frolkis, I. Shapira, D. Schwartz, Y. Yuhas, I. F. Schwartz, T. Chernichovski, and G. Uretzky
Heparin Added to Cardioplegic Solution Inhibits Tumor Necrosis Factor-{alpha} Production and Attenuates Myocardial Ischemic-Reperfusion Injury
Chest,
September 1, 2005;
128(3):
1805 - 1811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. V. Naidu, S. M. Woolley, A. S. Farivar, R. Thomas, C. H. Fraga, C. H. Goss, and M. S. Mulligan
Early tumor necrosis factor-{alpha} release from the pulmonary macrophage in lung ischemia-reperfusion injury
J. Thorac. Cardiovasc. Surg.,
May 1, 2004;
127(5):
1502 - 1508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Rossoni, B. Manfredi, V. Cavalca, R. Razzetti, S. Bongrani, G. L. Polvani, and F. Berti
The Aminotetraline Derivative ({+/-})-(R,S)-5,6-Dihydroxy-2-methylamino-1,2,3,4-tetrahydro-naphthalene Hydrochloride (CHF-1024) Displays Cardioprotection in Postischemic Ventricular Dysfunction of the Rat Heart
J. Pharmacol. Exp. Ther.,
November 1, 2003;
307(2):
633 - 639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Paz, I. Frolkis, D. Pevni, I. Shapira, Y. Yuhas, A. Iaina, Y. Wollman, T. Chernichovski, N. Nesher, C. Locker, et al.
Effect of tumor necrosis Factor-Alphaon endothelial and inducible nitric oxidesynthase messenger ribonucleic acidexpression and nitric oxide synthesisin ischemic and nonischemic isolated rat heart
J. Am. Coll. Cardiol.,
October 1, 2003;
42(7):
1299 - 1305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. F. Maurus, D. Schmidt, M. K. J. Schneider, M. I. Turina, J. D. Seebach, and G. Zund
Hypoxia and reoxygenation do not upregulate adhesion molecules and natural killer cell adhesion on human endothelial cells in vitro
Eur J Cardiothorac Surg,
June 1, 2003;
23(6):
976 - 983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Calabresi, G. Rossoni, M. Gomaraschi, F. Sisto, F. Berti, and G. Franceschini
High-Density Lipoproteins Protect Isolated Rat Hearts From Ischemia-Reperfusion Injury by Reducing Cardiac Tumor Necrosis Factor-{alpha} Content and Enhancing Prostaglandin Release
Circ. Res.,
February 21, 2003;
92(3):
330 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Krishnadasan, B. V. Naidu, K. Byrne, C. Fraga, E. D. Verrier, and M. S. Mulligan
The role of proinflammatory cytokines in lung ischemia-reperfusion injury
J. Thorac. Cardiovasc. Surg.,
February 1, 2003;
125(2):
261 - 272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Goette, M. Arndt, C. Rocken, T. Staack, R. Bechtloff, D. Reinhold, C. Huth, S. Ansorge, H. U. Klein, and U. Lendeckel
Calpains and cytokines in fibrillating human atria
Am J Physiol Heart Circ Physiol,
July 1, 2002;
283(1):
H264 - H272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Maekawa, H. Wada, T. Kanda, T. Niwa, Y. Yamada, K. Saito, H. Fujiwara, K. Sekikawa, and M. Seishima
Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-{alpha}
J. Am. Coll. Cardiol.,
April 3, 2002;
39(7):
1229 - 1235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Stangl, G. Baumann, K. Stangl, and S. B Felix
Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion
Cardiovasc Res,
January 1, 2002;
53(1):
12 - 30.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Stamm, I. Friehs, D. B. Cowan, A. M. Moran, H. Cao-Danh, L. F. Duebener, P. J. del Nido, and F. X. McGowan Jr
Inhibition of Tumor Necrosis Factor-{alpha} Improves Postischemic Recovery of Hypertrophied Hearts
Circulation,
September 18, 2001;
104(2009):
I-350 - I-355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Formigli, L. I. Manneschi, C. Nediani, E. Marcelli, G. Fratini, S. Zecchi Orlandini, and A. M. Perna
Are macrophages involved in early myocardial reperfusion injury?
Ann. Thorac. Surg.,
May 1, 2001;
71(5):
1596 - 1602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Frolkis, J. Gurevitch, Y. Yuhas, A. Iaina, Y. Wollman, T. Chernichovski, Y. Paz, M. Matsa, D. Pevni, A. Kramer, et al.
Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemia
J. Am. Coll. Cardiol.,
January 1, 2001;
37(1):
316 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Grandel, L. Fink, A. Blum, M. Heep, M. Buerke, H.-J. Kraemer, K. Mayer, R. M. Bohle, W. Seeger, F. Grimminger, et al.
Endotoxin-Induced Myocardial Tumor Necrosis Factor-{alpha} Synthesis Depresses Contractility of Isolated Rat Hearts : Evidence for a Role of Sphingosine and Cyclooxygenase-2-Derived Thromboxane Production
Circulation,
November 28, 2000;
102(22):
2758 - 2764.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Belosjorow, R. Schulz, H. Dorge, F. U. Schade, and G. Heusch
Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits
Am J Physiol Heart Circ Physiol,
December 1, 1999;
277(6):
H2470 - H2475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wan and A. P. C. Yim
Cytokines in myocardial injury: impact on cardiac surgical approach
Eur J Cardiothorac Surg,
September 1, 1999;
16(Supplement_1):
S107 - S111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Simms and K. R. Walley
Activated macrophages decrease rat cardiac myocyte contractility: importance of ICAM-1-dependent adhesion
Am J Physiol Heart Circ Physiol,
July 1, 1999;
277(1):
H253 - H260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Li, B. Yang, and J. L. Mehta
Tumor necrosis factor-{alpha} enhances hypoxia-reoxygenation-mediated apoptosis in cultured human coronary artery endothelial cells: critical role of protein kinase C
Cardiovasc Res,
June 1, 1999;
42(3):
805 - 813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Claeys, J. Bosmans, L. Veenstra, P. Jorens, Herbert De Raedt, and C. J. Vrints
Determinants and Prognostic Implications of Persistent ST-Segment Elevation After Primary Angioplasty for Acute Myocardial Infarction : Importance of Microvascular Reperfusion Injury on Clinical Outcome
Circulation,
April 20, 1999;
99(15):
1972 - 1977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nicoletti and J.-B. Michel
Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors
Cardiovasc Res,
March 1, 1999;
41(3):
532 - 543.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|